Albarico, Baby Girl .
HRN: 22-18-76 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/16/2022
AMPICILLIN 500MG (VIAL)
11/16/2022
11/23/2022
IV
185 Mg
Q12
PSNB; PROM 39 H; THICKLY MSAF
Waiting Final Action
Indication: Prophylaxis Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes